Showing results (181-190 of 274) with videos related to

Sort By:
Pageof 28
Plos One|November 7, 2019
Correction: KML001 Induces Apoptosis and Autophagic Cell Death in Prostate Cancer Cells via Oxidative Stress PathwayDalsan You, Yunlim Kim, Myoung Jin Jang, et al.
Medical Oncology (Northwood, London, England)|March 31, 2012
Comparative efficacy of vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI) and mammalian target of rapamycin (mTOR) inhibitor as second-line therapy in patients with metastatic renal cell carcinoma after the failure of first-line VEGF TKIKwonoh Park, Jae-Lyun Lee, Inkeun Park, et al.
Journal of Clinical Medicine|June 1, 2019
Effect of Ketorolac on the Prevention of Postoperative Catheter-Related Bladder Discomfort in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy: A Randomized, Double-Blinded, Placebo-Controlled StudyJun-Young Park, Jun Hyuk Hong, Jihion Yu, et al.
Korean Journal of Urology|March 13, 2015
Clinicopathological features of Xp11.2 translocation renal cell carcinomaBumjin Lim, Dalsan You, In Gab Jeong, et al.
The Journal of Urology|October 28, 2008
Effect of IN-1130, a small molecule inhibitor of transforming growth factor-beta type I receptor/activin receptor-like kinase-5, on prostate cancer cellsGeun Taek Lee, Jun Hyuk Hong, Thomas J Mueller, et al.
Korean Journal of Urology|December 24, 2013
Preoperative factors predictive of posterolateral extracapsular extension after radical prostatectomySahyun Pak, Sejun Park, Jeman Ryu, et al.
Scientific Reports|May 7, 2025
Comparative analysis of oncologic outcomes in surgically treated patients with renal cell carcinoma and renal vein thrombosis by pathologic subtypesDongrul Shin, Bumjin Lim, Cheryn Song, et al.
Cancer Research and Treatment|April 7, 2010
Efficacy and safety of docetaxel plus prednisolone chemotherapy for metastatic hormone-refractory prostate adenocarcinoma: single institutional study in KoreaJae-Lyun Lee, Jeong Eun Kim, Jin-Hee Ahn, et al.
Journal of Cancer Research and Clinical Oncology|April 23, 2014
Active surveillance for metastatic or recurrent renal cell carcinomaInkeun Park, Jae-Lyun Lee, Jin-Hee Ahn, et al.
International Journal of Clinical and Experimental Pathology|January 1, 2015
VEGF/VEGFR2 and PDGF-B/PDGFR-β expression in non-metastatic renal cell carcinoma: a retrospective study in 1,091 consecutive patientsSang Hoon Song, In Gab Jeong, Dalsan You, et al.
Pageof 28